| Title |
Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, November 2013
|
| DOI | 10.1007/s00228-013-1611-8 |
| Pubmed ID | |
| Authors |
Rodrigo C. Santos, Ana Paula C. de Faria, Natália R. Barbaro, Rodrigo Modolo, Silvia E. Ferreira-Melo, José R. Matos-Souza, Otávio R. Coelho, Juan C. Yugar-Toledo, Vanessa Fontana, David Calhoun, Heitor Moreno |
| Abstract |
Left ventricular hypertrophy and diastolic dysfunction (LVDD) remain highly frequent markers of cardiac damage and risk of progression to symptomatic heart failure, especially in resistant hypertension (RHTN). We have previously demonstrated that administration of sildenafil in hypertensive rats improves LVDD, restoring phosphodiesterase type 5 (PDE-5) inhibition in cardiac myocytes. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Unknown | 56 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 19% |
| Student > Ph. D. Student | 8 | 14% |
| Student > Bachelor | 7 | 12% |
| Student > Master | 5 | 9% |
| Other | 3 | 5% |
| Other | 8 | 14% |
| Unknown | 15 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 26% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
| Nursing and Health Professions | 5 | 9% |
| Agricultural and Biological Sciences | 4 | 7% |
| Neuroscience | 3 | 5% |
| Other | 9 | 16% |
| Unknown | 16 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2020.
All research outputs
#6,935,655
of 22,741,406 outputs
Outputs from European Journal of Clinical Pharmacology
#765
of 2,553 outputs
Outputs of similar age
#81,910
of 302,057 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#7
of 28 outputs
Altmetric has tracked 22,741,406 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,553 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 302,057 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.